BECTON, DICKINSON AND COMPANY Becton, Dickinson and Company Stock
Equities
BDX
US0758871091
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 237.3 USD | +0.97% |
|
+1.59% | -2.68% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
| Sales 2024 * | 20.23B 27.52B | Sales 2025 * | 21.42B 29.14B | Capitalization | 68.58B 93.28B |
|---|---|---|---|---|---|
| Net income 2024 * | 2.12B 2.88B | Net income 2025 * | 2.48B 3.37B | EV / Sales 2024 * | 4.04 x |
| Net Debt 2024 * | 13.21B 17.97B | Net Debt 2025 * | 10.71B 14.56B | EV / Sales 2025 * | 3.7 x |
| P/E ratio 2024 * |
32.6
x | P/E ratio 2025 * |
29.5
x | Employees | 73,000 |
| Yield 2024 * |
1.58% | Yield 2025 * |
1.62% | Free-Float | 77.74% |
More Fundamentals
* Assessed data
More news
Latest transcript on Becton, Dickinson and Company
More recommendations
More press releases
| 1 day | +0.97% | ||
| 1 week | +1.59% | ||
| Current month | +1.15% | ||
| 1 month | +1.09% | ||
| 3 months | -1.11% | ||
| 6 months | +1.51% | ||
| Current year | -2.68% |
1 week
233.73
238.95
1 month
229.40243.28
Current year
229.40249.89
1 year
229.40287.32
3 years
215.90287.32
5 years
197.75287.32
10 years
112.15287.32
| Managers | Title | Age | Since |
|---|---|---|---|
Thomas Polen
CEO | Chief Executive Officer | 50 | 08-12-31 |
| Director of Finance/CFO | 52 | 21-09-05 | |
| Chief Tech/Sci/R&D Officer | 48 | 18-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Bertram Scott
BRD | Director/Board Member | 73 | 02-09-23 |
Catherine Burzik
BRD | Director/Board Member | 73 | 13-01-28 |
| Director/Board Member | 69 | 10-07-25 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 15.40% | 254 M€ | +9.50% | - | |
| 2.47% | 6 M€ | +16.84% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-15 | 237.3 | +0.97% | 1,167,984 |
| 24-05-14 | 235 | -0.82% | 1,049,467 |
| 24-05-13 | 237 | +0.54% | 1,073,151 |
| 24-05-10 | 235.7 | +0.29% | 2,034,396 |
| 24-05-09 | 235 | +0.61% | 1,921,789 |
Delayed Quote Nyse, May 15, 2024 at 04:00 pm
More quotes
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows:
- medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.;
- diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.;
- clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc.
Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Calendar
2024-06-09
- Ex-dividend day
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A
Sell
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
237.3
USD
Average target price
278.8
USD
Spread / Average Target
+17.50%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -2.68% | 67.92B | |
| -4.98% | 181B | |
| +2.84% | 112B | |
| +4.53% | 50.1B | |
| +8.00% | 44.27B | |
| +9.65% | 40.41B | |
| +25.30% | 31.95B | |
| -0.17% | 25.82B | |
| +21.57% | 25.29B | |
| -0.59% | 24.68B |
- Stock Market
- Equities
- BDX Stock